Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 10685652

High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer J Sci Am
Publication date
2000 Feb
First author
Atkins MB

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Atkins MB
      type
      Author
    2. name
      Kunkel L
      type
      Author
    3. name
      Sznol M
      type
      Author
    4. name
      Rosenberg SA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Atkins MB
      type
      Author
    2. name
      Kunkel L
      type
      Author
    3. name
      Sznol M
      type
      Author
    4. name
      Rosenberg SA
      type
      Author
    bibliography ids
    1. nci-bib-b3e6befc3fe538aa82a66262
    book metadata
    content sha256
    30dd8eb50c522752ac79830be3f83769ce0252b19cb33e2617dfbc1e5af4f1b2
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:10685652
      immutable id
      pubmed:10685652@30dd8eb50c522752ac79830be3f83769ce0252b19cb33e2617dfbc1e5af4f1b2
      journal
      abbreviation
      Cancer J Sci Am
      issn electronic
      Source null
      issn print
      1081-4442
      issue
      Source null
      name
      The cancer journal from Scientific American
      nlm unique id
      9513568
      pages
      S11-4
      volume
      6 Suppl 1
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        10685652
        provenance
        batch id
        40703d4bdd5a70d2c67a
        provider
        NCBI PubMed ESummary
        record sha256
        14888aebae99dc90577c6f21fb438e2b39581f28abd35e3df205be0db520f8d1
        response sha256
        a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
        retrieved at
        2026-09-09T23:45:35.800055+00:00
        publication date
        display
        2000 Feb
        precision
        month
        year
        2000
        publication types
        1. Journal Article
        2. Research Support, Non-U.S. Gov't
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/10685652/
        title
        High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update.

        Preserved source evidence · Not medical advice